Cellular Distrubtion, Purification, and Molecular Nature of Human Ia Antigens
Overview
Affiliations
Human Ia antigens were extensively purified (1390-fold increase in specific activity) in 32% yield from BRI 8 cells, a lymphoblastoid B-cell line. Purification was monitored by using allogeneic antisera arising by foetal-maternal stimulation. The product, a glycoprotein fraction, contained the Ia antigens, the HLA-A and -B antigens, and a glycoprotein of unknown function. The glycoprotein fraction was composed of four glycosylated polypeptides with molecular weights of 43,000, 39,000, 33,000, and 28,000, and beta2-microglobulin; no polypeptide was linked to another by disulphide bridges. The A and B antigens only were absorbed by antibody against beta2-microglobulin. The Ia antigens comprised one each of the 33,000 and 28,000 molecular weight glycosylated polypeptides noncovalently linked together. Thus, only these chains were absorbed by xenogeneic anti-Ia antisera and were cross-linked by dimethyl-3-3'-dithiobispropionimidate dihydrochloride. The dimeric molecule bound deoxycholate (0.26 g/g of protein) and, when solubilized in deoxycholate, has a molecular weight of 77,000. The Ia allo- and xeno-antigenic activities were labile to heating and proteolysis and are probably determined by the polypeptide structure. Xenogeneic specific anti-Ia antisera were raised in rabbits and mice by immunizing with the glycoprotein fraction. These antisera reacted with B lymphocytes and monocytes but not T lymphocytes and fibroblasts. Their Fab fragments blocked the cytotoxicity of the allogeneic antisera for B lymphocytes and were potent inhibitors of the mixed lymphocyte reaction.
Expression of ia antigens by murine keratinizing epithelial langerhans cells.
Rowden G, Phillips T, Delovitch T Immunogenetics. 2011; 7(1):465-78.
PMID: 21302100 DOI: 10.1007/BF01844036.
Immunologic diagnosis and monitoring of human acute leukemias: a review.
Maheu M, Baker M, Falk J, Taub R Am J Pathol. 1981; 103(1):139-58.
PMID: 7013493 PMC: 1903806.
Seymour G, Greaves M, Janossy G Clin Exp Immunol. 1980; 39(1):66-75.
PMID: 6993067 PMC: 1537941.
Lucivero G, Lawton A, Cooper M Clin Exp Immunol. 1981; 45(1):185-90.
PMID: 6975679 PMC: 1537242.
Beckman I, Bradley J, Brooks D, Kupa A, McNamara P, Thomas M Clin Exp Immunol. 1980; 40(3):593-601.
PMID: 6968260 PMC: 1538949.